Full name
"ALLIANCE PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.1 - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46 - Wholesale trade of pharmaceutical and medical products
70.2 - Business and management consultancy activities
71.2 - Technical testing and analysis
72.1 - Scientific research and development in natural and technical sciences
73.1 - Advertising
74.9 - Other professional, scientific and technical activities, not elsewhere classified
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -14,9 | -3 | -1 | 68,3 |
Gross profit (loss) | -8 | 3,7 | -1 | -125,7 |
EBITDA | -8,1 | 3,7 | -1 | -125,7 |
Short time liabilities | 2,9 | 1,9 | 2,8 | 44,9 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | 0,2 | -2,8 | -3,8 | -33,9 |
Operating profit (EBIT) | -8,1 | 3,7 | -1 | -125,7 |
Assets | 5 | 0,1 | 0 | -100 |
Net profit (loss) | -8 | 3,7 | -1 | -125,7 |
Cash | 3,8 | 0,1 | 0 | -100 |
Liabilities and provisions for liabilities | 4,8 | 2,9 | 3,8 | 29,8 |
Net income from sale | 0 | 0 | 0 | 0 |
Working assets | 5 | 0,1 | 0 | -100 |
Other income costs | 6,8 | 6,8 | 0 | -100 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -4086 | -131,7 | 25,3 | 157 |
Equity capital to total assets | 3,9 | -3172 | -3175,9 | |
Gross profit margin | -26,7 | |||
EBITDA Margin | -29 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 1.727017879486084 | 0.04605785384774208 | 0 | 0 |
Net dept to EBITDA | 0.21425984799861908 | -0.02394627220928669 | 0 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane